3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
6
Leukemia, Myeloid, Acute
4
Uveal Melanoma
2
Lymphoma
2
Leukemia
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Select Advanced Solid Tumors
1
Recurrence
1
Rectal Neoplasms
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Meningeal Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Myeloid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Kidney Diseases
1
Gastrointestinal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Interventions
Specimen Handling
6
Human Papillomavirus DNA Tests
4
Colposcopy
4
Papillomavirus Vaccines
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Cisplatin
2
Carboplatin
2
toripalimab
1
epigallocatechin gallate
1
Transurethral Resection of Prostate
1
Standing Orders
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Platinum
1
Methods
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Educational Status
1
Early Intervention, Educational
1
Drug Therapy
1
Docetaxel
1
Clinical Protocols
1
Chemoradiotherapy
1
Bevacizumab
1
Benzethonium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Interleukin-2
×
90 days
×
Clear all
No trials found.